Observational studyThoracic cancer2016

Quantification of epidermal growth factor receptor (EGFR) mutation may be a predictor of EGFR-tyrosine kinase inhibitor treatment response.

Ha Young Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.